XBKK
PR9
Market cap486mUSD
Nov 12, Last price
20.80THB
Name
Praram 9 Hospital PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Praram 9 Hospital Public Company Limited manages Praram 9 Hospital, a prominent medical institution located in Thailand. This facility delivers a broad spectrum of tertiary healthcare services, encompassing health promotion, preventative medicine, thorough diagnosis, effective treatment, and comprehensive rehabilitation. Its core medical specialties include obstetrics and gynecology, general surgery, internal medicine, pediatrics, advanced kidney transplantation, cardiovascular care, and orthopedics. The hospital further distinguishes itself with numerous specialized centers, addressing areas such as diabetes and metabolic conditions, gastroenterology and hepatobiliary issues, neurological disorders, routine health check-ups, urgent care, physical therapy and rehabilitation, advanced imaging (radiology), ophthalmology, otolaryngology (ear, nose, and throat), dentistry, mental well-being, dermatology and cosmetic procedures, breast health, joint care, spinal conditions, allergy management, oncology, sleep disorders, pulmonary and respiratory diseases, wellness programs, and LASIK eye surgery. Established in 1992, the company maintains its primary base of operations in Bangkok, Thailand.
Key people
Bhanapot Damapong
Non-Executive Chairman of the Board · since 2018
Executive Vice Chairman of the Board, Chief Executive Officer · since 2018
Teeraphan Disayabutara
Chief Financial Officer, Deputy Managing Director - Accounting and Finance Department · since 2019
Charoen Nudpobsuk
Deputy Managing Director - Management Department · since 2019
Viroon Mavichak
Deputy Managing Director - Medical Department, Executive Director · since 2018
Somchai Pinyopornpanich
Executive Director · since 2023
Songsak Premsuk
Executive Director · since 2023
Prasert Trairatvorakul
Deputy Managing Director - Nursing and Medical Services Department, Executive Director · since 2018
Suree Apichayaphorn
Deputy Division Manager · since 2023
Sasivimon Suksa
Head of Internal Audit · since 2023
Marisa Thanasaksiri
Company Secretary, Head of Compliance · since 2023
Non-Executive Director · since 2018
Non-Executive Director · since 2018
Sirintara Ayudhaya
Non-Executive Independent Director · since 2018
Piset Chiyasak
Non-Executive Independent Director · since 2018
Kanit Patsaman
Non-Executive Independent Director · since 2018
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||